#Laboratorios #Farmaceuticos #Rovi #Injectable #Depot #Technology for #Treating #Schizophrenia
Congratulations for the continued successes of Rovi Pharmaceutical Co. (Laboratorios Farmaceuticos ROVI)! They have developed an injectable depot kit for once-a-month administration for the treatment of schizophrenia and other risperidone/paliperidone-responsive disorders. The EP launch is ready!
They have a robust EP and US (http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=rovi&FIELD1=ASNM&co1=AND&TERM2=laboratorios&FIELD2=AANM&d=PTXT) patent portfolio protecting their product.